Sysmex ADR Common Stock Net 2016-2024 | SSMXY
Sysmex ADR common stock net from 2016 to 2024. Common stock net can be defined as the value of common equity ownership.
- Sysmex ADR common stock net for the quarter ending December 31, 2024 was $0.094B, a 21.82% decline year-over-year.
- Sysmex ADR common stock net for 2024 was $0.098B, a 7.71% decline from 2023.
- Sysmex ADR common stock net for 2023 was $0.106B, a 15.85% decline from 2022.
- Sysmex ADR common stock net for 2022 was $0.126B, a 5.38% increase from 2021.
| Sysmex ADR Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $98 |
| 2023 | $106 |
| 2022 | $126 |
| 2021 | $119 |
| 2020 | $118 |
| 2019 | $114 |
| 2018 | $116 |
| 2017 | $104 |
| 2016 | $97 |
| Sysmex ADR Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2024-06-30 | $94 |
| 2023-06-30 | $106 |
| 2022-06-30 | $109 |
| 2021-06-30 | $121 |
| 2020-06-30 | $121 |
| 2019-06-30 | $116 |
| 2018-06-30 | $114 |
| 2017-06-30 | $105 |
| 2016-06-30 | $105 |
| 2016-03-31 | $97 |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.550B | $3.340B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.969B | 86.71 |
| Thermo Fisher Scientific (TMO) | United States | $152.062B | 18.39 |
| Edwards Lifesciences (EW) | United States | $45.884B | 30.08 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $41.285B | 47.45 |
| DexCom (DXCM) | United States | $33.643B | 52.00 |
| IQVIA Holdings (IQV) | United States | $24.277B | 13.60 |
| STERIS (STE) | Ireland | $24.092B | 26.57 |
| Mettler-Toledo (MTD) | United States | $24.015B | 28.56 |
| Waters (WAT) | United States | $20.783B | 29.32 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.675B | 0.00 |
| Hologic (HOLX) | United States | $13.854B | 15.05 |
| Penumbra (PEN) | United States | $10.339B | 81.15 |
| Masimo (MASI) | United States | $8.811B | 32.50 |
| Globus Medical (GMED) | United States | $8.012B | 19.09 |
| Teleflex (TFX) | United States | $5.403B | 8.92 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| TransMedics (TMDX) | United States | $4.300B | 93.47 |
| Integer Holdings (ITGR) | United States | $4.144B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.209B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.358B | 14.04 |
| Veracyte (VCYT) | United States | $2.084B | 29.24 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.996B | 17.94 |
| Alphatec Holdings (ATEC) | United States | $1.817B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.320B | 0.00 |
| Artivion (AORT) | United States | $1.263B | 118.32 |
| Pulse Biosciences (PLSE) | United States | $1.164B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.747B | 0.00 |
| IRadimed (IRMD) | United States | $0.736B | 37.34 |
| RxSight (RXST) | United States | $0.621B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.581B | 9.04 |
| Delcath Systems (DCTH) | United States | $0.565B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 12.87 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.446B | 11.87 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.441B | 0.00 |
| NeuroPace (NPCE) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.414B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.289B | 0.00 |
| Neuronetics (STIM) | United States | $0.257B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.92 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| 908 Devices (MASS) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Accuray (ARAY) | United States | $0.158B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.153B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.153B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.60 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.23 |